Danlag, Baby Girl .

HRN: 29-45-27  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/09/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
08/09/2026
08/16/2026
IV
15mg
Q36H
NAMF (PROM X 72H)
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Unspecified Sepsis    Compliance to guidelines: